Tarik Skubal threw 40 pitches in a sim game Tuesday as elbow recovery progresses

What happened

Tarik Skubal threw 40 pitches across three simulated innings on Tuesday, a meaningful early marker in his recovery from elbow surgery performed earlier this month to remove a loose body. Per Chris McCosky of the Detroit News, the left-hander is scheduled to throw another sim game on Monday. The Detroit Tigers have declined to attach a specific timeline to his return.

Skubal is on the injured list — pitchers are eligible for the 15-day IL under general league rules — and the club is managing his progression with deliberate caution. That caution is warranted, and not only because of the usual anxieties that accompany any pitcher's elbow procedure.

Why it matters

The procedure itself is the story within the story. Skubal's surgery was performed using a device called the NanoNeedle, which MLB Trade Rumors describes as smaller than a traditional arthroscope. The logic is straightforward enough: a smaller instrument means a smaller incision, and a smaller incision means, in theory, less swelling, less pain, and a shorter recovery window.

The catch — and it is a meaningful one — is that Skubal is reportedly the first MLB player to undergo surgery with this device. There is no track record. No comparable case to point to. No prior patient who came back in eight weeks or twelve weeks or twenty weeks and gave the Tigers a benchmark to work from. The optimism embedded in the NanoNeedle's design is real, but it is optimism without precedent, which is a different thing entirely from a proven protocol.

MLB Trade Rumors notes that a conventional loose-body removal in a pitcher's elbow would typically require an absence of roughly three months, if not longer. Per the report, Skubal could return more quickly, but the framing is plain: he is in uncharted waters. The Tigers' reluctance to name a date is not evasiveness — it is the only honest answer available when the surgical approach itself has never been tested at this level.

Where the club stands

Detroit carries a 76-86 record, sitting fourth in the AL Central, 9 games back in the division. The Tigers have been eliminated from both the division race and the Wild Card race, and they enter Thursday's home game against the Los Angeles Angels on a one-game losing streak. The Wild Card standing — ranked 8th, 8.0 games relative to the cut line — underscores the operational reality: the Tigers are not managing Skubal's return against a playoff push. They are managing it against the calendar, against the integrity of his arm, and against the longer arc of what he means to this franchise. That context does not make the recovery less urgent; it arguably makes it more careful.

Detroit hosts the Los Angeles Angels on Thursday at Comerica Park, with Jack Flaherty drawing the probable start opposite Grayson Rodriguez. The club then travels to Rate Field for back-to-back games against the Chicago White Sox on Friday and Saturday, with Troy Melton lined up Friday against Erick Fedde and Framber Valdez scheduled Saturday opposite Anthony Kay.

The schedule is manageable, and the Tigers are not in a position where they need to rush anyone back to salvage a standing. Fourth place in the AL Central, eliminated from both races, is a difficult place to be — but it is also a place where a franchise can afford to let its best pitcher throw sim games on his own schedule rather than the standings' schedule.

What we don't know yet

The Tigers have not offered a target date for Skubal's return, and given the novelty of the NanoNeedle procedure, that silence is not a gap in the reporting — it is the reporting. There is genuinely no established recovery curve to cite. The 40-pitch sim game on Tuesday is encouraging as a data point, and Monday's planned session will add another, but the line between "progressing well" and "ready to face major-league hitters in a game that counts" is long and has several checkpoints still ahead.

Under general league rules, a pitcher on a rehab assignment has up to 30 days before he must be activated or moved. That clock has not started yet — Skubal is still in the sim-game phase, which precedes a formal rehab assignment. How quickly he moves from sim games to live batting practice to a rehab outing, and how his elbow responds at each stage, will determine whether the NanoNeedle's theoretical advantages translate into an actual accelerated return.

MLB Trade Rumors is careful not to promise one. The desk will be equally careful not to imply one.

What to watch

Monday's sim game is the next concrete milestone. If Skubal comes through it cleanly and the Tigers begin discussing a rehab assignment, that would signal the recovery is tracking ahead of the conventional three-month window. If the club continues to stay quiet on timelines after Monday, that is its own kind of information.

Longer term, Skubal's case will be watched well beyond Detroit. As reportedly the first MLB player to undergo surgery with the NanoNeedle device, his recovery — its pace, its complications or lack thereof, its eventual outcome — will function as the proof of concept for a procedure that, right now, has exactly one data point. That data point is currently throwing sim games in Detroit and planning to throw another one Monday.

The Tigers are not saying when he comes back. Per MLB Trade Rumors, the honest answer is that nobody can say yet. What is on record is that he is throwing, that the pitch count is climbing, and that the next step is already scheduled. In a recovery defined by uncertainty, that is not nothing.